It was reported that Bcl2 can determine the resistance of 5-Fu in carcinoma [15, 16]; hence, we supposed PVT1 may possibly enhance 5-fu resistance in GC via its promotion to Bcl2. The gene discussed is BCL2; the disease is gastric cancer.